ZNF99
gene geneOn this page
Also known as MGC24986
Summary
ZNF99 (zinc finger protein 99, HGNC:13175) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 99 (A8MXY4). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7652 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 179 total
- MANE Select transcript:
NM_001080409
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13175 |
| Approved symbol | ZNF99 |
| Name | zinc finger protein 99 |
| Location | 19p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC24986 |
| Ensembl gene | ENSG00000213973 |
| Ensembl biotype | protein_coding |
| OMIM | 603981 |
| Entrez | 7652 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000596209
RefSeq mRNA: 1 — MANE Select: NM_001080409
NM_001080409
CCDS: CCDS59369
Canonical transcript exons
ENST00000596209 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002263497 | 22769198 | 22769324 |
| ENSE00002281070 | 22768305 | 22768400 |
| ENSE00002992853 | 22752183 | 22759682 |
| ENSE00003212809 | 22784014 | 22784151 |
Expression profiles
Bgee: expression breadth broad, 20 present calls, max score 82.87.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2868 / max 51.4610, expressed in 93 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180258 | 0.1688 | 69 |
| 180257 | 0.1180 | 28 |
Top tissues by expression
202 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.87 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.64 | gold quality |
| ventricular zone | UBERON:0003053 | 59.39 | gold quality |
| cortical plate | UBERON:0005343 | 58.39 | silver quality |
| ganglionic eminence | UBERON:0004023 | 56.22 | gold quality |
| lower lobe of lung | UBERON:0008949 | 51.37 | silver quality |
| testis | UBERON:0000473 | 51.31 | gold quality |
| buccal mucosa cell | CL:0002336 | 51.18 | gold quality |
| right testis | UBERON:0004534 | 50.10 | gold quality |
| left testis | UBERON:0004533 | 48.25 | gold quality |
| bone marrow cell | CL:0002092 | 47.89 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 46.34 | gold quality |
| sural nerve | UBERON:0015488 | 45.29 | gold quality |
| endometrium | UBERON:0001295 | 44.35 | silver quality |
| prefrontal cortex | UBERON:0000451 | 43.43 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| oviduct epithelium | UBERON:0004804 | 43.35 | gold quality |
| bone marrow | UBERON:0002371 | 43.08 | gold quality |
| kidney | UBERON:0002113 | 42.58 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| skin of hip | UBERON:0001554 | 42.54 | silver quality |
| cortex of kidney | UBERON:0001225 | 42.39 | gold quality |
| upper leg skin | UBERON:0004262 | 42.39 | silver quality |
| muscle tissue | UBERON:0002385 | 42.27 | gold quality |
| lymph node | UBERON:0000029 | 42.22 | gold quality |
| duodenum | UBERON:0002114 | 42.16 | gold quality |
| tonsil | UBERON:0002372 | 41.71 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 41.62 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 41.54 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.72 |
| E-MTAB-6142 | no | 25.38 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
217 targeting ZNF99, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
Cross-species orthologs
30 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf646 | ENSDARG00000061424 |
| danio_rerio | si:dkey-154p10.3 | ENSDARG00000068366 |
| danio_rerio | si:dkey-89b17.4 | ENSDARG00000075545 |
| danio_rerio | zgc:66472 | ENSDARG00000075916 |
| danio_rerio | si:ch211-148l7.4 | ENSDARG00000094469 |
| danio_rerio | znf576.1 | ENSDARG00000097819 |
| drosophila_melanogaster | Sry-delta | FBGN0003512 |
| drosophila_melanogaster | az2 | FBGN0025185 |
| drosophila_melanogaster | hang | FBGN0026575 |
| drosophila_melanogaster | CG3032 | FBGN0029928 |
| drosophila_melanogaster | CG2129 | FBGN0030008 |
| drosophila_melanogaster | CG11695 | FBGN0030316 |
| drosophila_melanogaster | CG8944 | FBGN0030680 |
| drosophila_melanogaster | CG7101 | FBGN0030963 |
| drosophila_melanogaster | CG1602 | FBGN0033186 |
| drosophila_melanogaster | CG18011 | FBGN0033491 |
| drosophila_melanogaster | CG12942 | FBGN0033569 |
| drosophila_melanogaster | CG8089 | FBGN0033993 |
| drosophila_melanogaster | indra | FBGN0035213 |
| drosophila_melanogaster | CG10654 | FBGN0036294 |
| drosophila_melanogaster | CG6791 | FBGN0037918 |
| drosophila_melanogaster | CG17803 | FBGN0038547 |
| drosophila_melanogaster | CG12219 | FBGN0043796 |
| drosophila_melanogaster | CG30020 | FBGN0050020 |
| drosophila_melanogaster | pzg | FBGN0259785 |
| drosophila_melanogaster | mld | FBGN0263490 |
| drosophila_melanogaster | zf30C | FBGN0270924 |
| caenorhabditis_elegans | ztf-15 | WBGENE00011066 |
| caenorhabditis_elegans | WBGENE00013734 | |
| caenorhabditis_elegans | WBGENE00015649 |
Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF688 (ENSG00000229809)
Protein
Protein identifiers
Zinc finger protein 99 — A8MXY4 (reviewed: A8MXY4)
All UniProt accessions (1): A8MXY4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001073878* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (28 total): zinc finger region 24, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MXY4-F1 | 72.18 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 85 (showing top):
chr19p12, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, HMGA1_TARGET_GENES, MIR335_3P, MIR548E_5P, MIR548N, MIR23A_3P_MIR23B_3P, MIR23C, MIR6809_3P, MIR4753_3P, MIR561_3P
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
390 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF99 | OR4K15 | Q8NH41 | 447 |
| ZNF99 | OR10S1 | Q8NGN2 | 446 |
| ZNF99 | OR5W2 | Q8NH69 | 430 |
| ZNF99 | OR5D13 | Q8NGL4 | 417 |
| ZNF99 | OR5AR1 | Q8NGP9 | 411 |
| ZNF99 | OR5D18 | Q8NGL1 | 398 |
| ZNF99 | OR5P2 | Q8WZ92 | 394 |
| ZNF99 | OR8K3 | Q8NH51 | 380 |
| ZNF99 | DEFB115 | Q30KQ5 | 371 |
| ZNF99 | ZNF280A | P59817 | 352 |
| ZNF99 | TMEM121 | Q9BTD3 | 349 |
| ZNF99 | FAM133B | Q5BKY9 | 348 |
| ZNF99 | WDR44 | Q5JSH3 | 332 |
| ZNF99 | TOGARAM2 | Q6ZUX3 | 323 |
| ZNF99 | FSD1L | Q9BXM9 | 320 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ECE1 | ZNF99 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (6): ZNF99 (Affinity Capture-MS), ZNF99 (PCA), ZNF99 (Negative Genetic), ZNF99 (Affinity Capture-MS), HSPA9 (Cross-Linking-MS (XL-MS)), ZNF99 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2VDQ7, A6NK75, A6NN14, A6NNF4, A8MQ14, A8MTY0, A8MXY4, B7Z6K7, E9QAG8, O43345, O75290, O75373, O75437, P0CJ79, P10751, P17017, P17019, P17035, P17038, P18749, P35789, P51522, Q03923, Q03938, Q05481, Q14585, Q3SYV7, Q4V348, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6P5C7, Q6ZN08, Q6ZN57, Q6ZR52, Q86V71, Q86XN6, Q8IYB9, Q8N7Q3
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
179 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 152 |
| Likely benign | 20 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
327 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:22769237:T:A | donor_gain | 1.0000 |
| 19:22769191:T:TA | donor_gain | 0.9900 |
| 19:22769192:CCTCA:C | donor_loss | 0.9900 |
| 19:22769193:CTCAC:C | donor_loss | 0.9900 |
| 19:22769194:TCAC:T | donor_loss | 0.9900 |
| 19:22769195:C:CC | donor_loss | 0.9900 |
| 19:22769196:A:AC | donor_gain | 0.9900 |
| 19:22769196:A:AG | donor_loss | 0.9900 |
| 19:22769196:AC:A | donor_gain | 0.9900 |
| 19:22769197:C:CC | donor_gain | 0.9900 |
| 19:22769197:C:CT | donor_loss | 0.9900 |
| 19:22769197:CC:C | donor_gain | 0.9900 |
| 19:22759683:C:CC | acceptor_gain | 0.9800 |
| 19:22759680:TAA:T | acceptor_gain | 0.9700 |
| 19:22769180:A:AC | donor_gain | 0.9700 |
| 19:22769322:TCC:T | acceptor_gain | 0.9700 |
| 19:22769323:CCC:C | acceptor_gain | 0.9700 |
| 19:22769181:A:C | donor_gain | 0.9600 |
| 19:22769325:C:CC | acceptor_gain | 0.9600 |
| 19:22768203:T:TA | donor_gain | 0.9500 |
| 19:22769321:ATCCC:A | acceptor_loss | 0.9500 |
| 19:22769322:TCCCT:T | acceptor_loss | 0.9500 |
| 19:22769323:CC:C | acceptor_gain | 0.9500 |
| 19:22769324:CC:C | acceptor_gain | 0.9500 |
| 19:22769324:CCT:C | acceptor_loss | 0.9500 |
| 19:22769325:CTGAA:C | acceptor_loss | 0.9500 |
| 19:22769326:T:C | acceptor_loss | 0.9500 |
| 19:22767927:A:C | acceptor_gain | 0.9400 |
| 19:22769320:GATCC:G | acceptor_gain | 0.9300 |
| 19:22768190:C:A | donor_gain | 0.9200 |
AlphaMissense
5807 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:22757767:A:C | F714L | 0.984 |
| 19:22757767:A:T | F714L | 0.984 |
| 19:22757769:A:G | F714L | 0.984 |
| 19:22757683:A:C | F742L | 0.982 |
| 19:22757683:A:T | F742L | 0.982 |
| 19:22757685:A:G | F742L | 0.982 |
| 19:22758019:A:C | F630L | 0.979 |
| 19:22758019:A:T | F630L | 0.979 |
| 19:22758021:A:G | F630L | 0.979 |
| 19:22758271:A:C | F546L | 0.979 |
| 19:22758271:A:T | F546L | 0.979 |
| 19:22758273:A:G | F546L | 0.979 |
| 19:22758187:A:C | F574L | 0.977 |
| 19:22758187:A:T | F574L | 0.977 |
| 19:22758189:A:G | F574L | 0.977 |
| 19:22757515:A:C | F798L | 0.973 |
| 19:22757515:A:T | F798L | 0.973 |
| 19:22757517:A:G | F798L | 0.973 |
| 19:22758523:A:C | F462L | 0.972 |
| 19:22758523:A:T | F462L | 0.972 |
| 19:22758525:A:G | F462L | 0.972 |
| 19:22758103:A:C | F602L | 0.971 |
| 19:22758103:A:T | F602L | 0.971 |
| 19:22758105:A:G | F602L | 0.971 |
| 19:22758170:A:G | L580P | 0.971 |
| 19:22757599:A:C | F770L | 0.966 |
| 19:22757599:A:T | F770L | 0.966 |
| 19:22757601:A:G | F770L | 0.966 |
| 19:22757935:A:C | F658L | 0.966 |
| 19:22757935:A:T | F658L | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000179427 (19:22768967 T>C), RS1000201581 (19:22754905 A>G), RS1000286838 (19:22774888 A>C), RS1000537393 (19:22770644 C>G,T), RS1000630032 (19:22761694 C>T), RS1000706867 (19:22773776 A>G), RS1000728636 (19:22767278 C>A), RS1000811849 (19:22775212 G>C,T), RS1000844361 (19:22768674 A>G), RS1000903614 (19:22779600 A>C), RS1000986858 (19:22771067 T>A,C,G), RS1001032144 (19:22784602 AAAG>A), RS1001396628 (19:22783886 C>A,G,T), RS1001774312 (19:22755175 G>A,C), RS1001939772 (19:22755337 C>A,T)
Disease associations
OMIM: gene MIM:603981 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.